Efficacy and Duration of Salmeterol Powder Inhalation in Protecting Against Exercise-Induced Bronchoconstriction

This publication has 9 references indexed in Scilit:

• Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol
  Respiratory Medicine, 1994
• Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma
  Respiratory Medicine, 1993
• The effect of salmeterol on the early‐ and late‐phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X
  Allergy, 1993
• Prevention of exercise induced asthma by inhaled salmeterol xinafoate.
  Archives of Disease in Childhood, 1992
• Protection against allergen-induced asthma by salmeterol
  The Lancet, 1990
• Duration of Protective Effect of Terbutaline Sulfate and Cromolyn Sodium Alone and in Combination on Exercise-induced Asthma
  Chest, 1990
• Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
  Thorax, 1988
• The duration of protection from exercise-induced asthma by inhaled salbutamol, and a comparison with inhaled reproterol
  Respiratory Medicine, 1983
• Exercise-induced asthma.
  Archives of Disease in Childhood, 1983